<DOC>
	<DOCNO>NCT01425528</DOCNO>
	<brief_summary>The purpose study identify dose Kuvan need normalize level tetrahydrobiopterin ( BH4 ) patient Guanosine Triphosphate Cyclohydrolase ( GTPCH ) deficiency asses potential impact oral Kuvan mood function individual GTPCH deficiency may experience symptom anxiety , depression , fatigue , trouble concentrating , memory loss . This phase one study . The investigator monitor patient period three six month medication . Medication level monitor measure BH4 level cerebral spinal fluid ( CSF ) . Patients undergo baseline lumbar puncture two follow-up lumbar puncture purpose . The investigator also monitor emotional function motor function .</brief_summary>
	<brief_title>Study Kuvan Treatment Adults With GTPCH Deficiency</brief_title>
	<detailed_description />
	<criteria>establish diagnosis GTPCH deficiency , support appropriate family history , CSF neurotransmitter study , skin fibroblast enzyme assay and/or mutation analysis minimum age 18 year identify self others symptom anxiety , depression , fatigue , neurocognitive dysfunction ( trouble concentrating , memory loss , etc ) willingness undergo least 2 CSF evaluation BH4 neurotransmitter level 8 12 week period age &lt; 18 year old unwillingness undergo repeat CSF analysis lack support diagnostic criterion concomitant medical problem medication would increase risk KuvanÂ® concomitant psychiatric state , severe depression suicidal ideation require immediate referral alternative treatment intervention prior history back surgery , abnormality chronic pain opinion investigator would increase risk associated lumbar puncture significant obesity might increase difficulty risk perform lumbar puncture female , unwillingness use birth control period study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>